AI-enabled, decision-ready competitive intelligence from a pharma-insider team. We help biopharma CI and brand leaders anticipate competitor moves, avoid strategic blind spots and make decisions that stay relevant from development through commercialization.
AdametNext is a biopharma competitive intelligence firm. We work as an extension of your CI and brand teams, connecting scientific, clinical, regulatory and commercial signals into one view you can act on.
Founded in 2019 by Virendra Kumar after a career leading CI and brand insights at Bayer, GSK and Novartis. Headquartered in Hyderabad, with teams in the US, UK and Singapore.
Former brand managers and CI leads interpret every signal in its clinical and commercial context.
Secondary, primary and congress intelligence, triangulated and confidence-rated.
Three proprietary AI platforms add speed and consistency. Our analysts own every conclusion.
Competitor decisions surface in secondary data 12–24 months after they are made.* By then, the window to respond has narrowed. We help you see those shifts at every stage of the asset.
Where is the science going?
Which assets are accelerating?
What will define differentiation?
How might the regulatory bar shift?
What will sustain standard of care?
What is changing?
What could it mean for our asset?
What should we prepare for now?
We answer all three questions, so leaders anticipate competitive change and make decisions that stay relevant from development through commercialization.
*AdametNext analysis of the lag between competitor decisions and IQVIA data, press releases, publications and abstracts.
Organized around your KITs and KIQs, not a fixed information feed. We run the full CI cycle, from the annual plan to the tools that run it.
See all CI services →Maintain strategic visibility
Test the critical unknowns
Capture inflection points
Our analysts bring hands-on experience from the brands and pipelines they have supported, not just the databases they have searched.
Built to raise the quality of pharma CI, bringing the inside-out perspective of a former brand and CI leader to every engagement.
Virendra Kumar starts ADN after a decade of client-side CI and brand roles at Bayer, GSK and Novartis.
Three global top-20 pharma companies, US biotechs and specialty pharma, across primary and secondary CI.
Hyderabad HQ and Delhi, Short Hills NJ, London and Singapore, plus freelance consultants across EU4, Canada, UAE and Australia.
Three proprietary AI platforms. SAMANVAY brings together India’s pharma GCC community, and ADN exhibits at Pharma CI USA.
SAMANVAY 2027, deeper AI-enabled CI and new therapy-area franchises.
Onshore consultants across major pharma markets, backed by our offshore delivery centre. A hybrid model that works around the clock.
Toronto
Short Hills, NJ
London
EU4
Dubai
Delhi
Hyderabad (HQ)
Singapore
BrisbaneAn emerging pharma GCC capital
New pharma GCCs, 2024–26: Eli Lilly · Amgen · BMS · MSD · Regeneron · Lonza
“We don’t just tell you what competitors are doing. We help you understand what it means for your business, and prepare for what comes next.”
Virendra Kumar · Founder & CEO
16+ years in pharma CI and brand insights · ex-Novartis Global CI Lead, Respiratory · Supported Ultibro, Enerzair & Atectura Breezhaler and Xolair PFS launches
Three proprietary platforms power our engagements: AI-enabled, human-validated and client-controlled.
Explore the platforms →
CI plans, KITs/KIQs, governed workflows, alerts and Ask CI search, with continuity across teams and years.
Coverage planning, live capture, task delegation and AI-enabled session insights, inside your secured IT environment.
Curated signals across companies, assets and trials, turned into company-specific implications for your portfolio.
3 global top-20 pharma companies, US biotechs, and specialty and biosimilar leaders, across therapy areas and indications.
More client voices →The shared insights were spot-on.
The attention to detail in finding business implications was commendable.
Signature white papers on how CI teams protect brand value and compete with clear ethical boundaries.
All thought leadership →Fresh perspectives from our CI practice and ADN Academy, published on LinkedIn.
Follow AdametNextOur latest thought leadership lives on LinkedIn. See all posts ↗
CI frameworks, congress takeaways, events and team news, in your feed every week.
We run the full CI cycle for biopharma CI and brand teams, connecting evidence to implications, and implications to action.
Always-on monitoring, question-led research and event-driven congress coverage, organized around your KITs and KIQs.
Maintain strategic visibility
Test the critical unknowns
Capture inflection points
From the annual CI plan to the tools that run it, while lowering the total cost of intelligence.
↻ Annual cycle: what we learn in execution shapes next year’s plan
Technology scales the workflow. Analysts remain accountable for the conclusion.
Monitor what matters to your KIQs
Triangulate and confidence-rate
Read it in clinical and commercial context
Model how competitors may respond
Implications and decision triggers
News summaries tell you what happened. CI leaders need to know what it means for their asset and what to do next, with a view they can defend in front of leadership.
What happened?
What does it mean for us?
What should we do?
Start with a single question and scale to a dedicated team as your needs grow.
Deep dives, landscapes and congress coverage for a defined question or event.
Continuous monitoring, alerts and monthly or quarterly reports against your CI plan.
A dedicated team integrated with your CI function, working as an extension of your team.
Three proprietary platforms power every engagement. AI brings speed and consistency; our pharma-trained analysts bring the business implications.
Plan, run and reuse competitive intelligence in one place, with a governed workflow from first signal to approved, disseminated insight.
Demos with Ananya Mehra, Assistant Client Management, AdametNext · Ananya.Mehra01@adametnext.com
Plan coverage, capture live, delegate tasks and turn sessions and abstracts into AI-enabled insight, all within your own secured IT ecosystem.
Demos with Ananya Mehra, Assistant Client Management, AdametNext · Ananya.Mehra01@adametnext.com
Curated signals across companies, assets and trials, analysed with AI and validated by analysts, then translated into implications specific to your portfolio and KIQs.
Demos with Ananya Mehra, Assistant Client Management, AdametNext · Ananya.Mehra01@adametnext.com
Our platforms are delivered as part of an engagement or as an optional subscription, and are configured to your KIQs, data and governance.
Book your demo →ADN CI Platform, ConferaIQ and ARISENTIQ are optional platform services offered by AdametNext; inclusion in an engagement is subject to the client’s subscription.
A pharma-insider team that works as an extension of your strategy function, curious enough to ask better questions and trusted enough to challenge assumptions.
“I built AdametNext to raise the quality of pharma CI, bringing the inside-out perspective of a former brand and CI leader to every engagement.”
Former client-side leaders from Novartis, Roche, MSD, Bayer and GSK, with top biopharma and global consulting experience, leading every engagement.
Strategic CI and foresight, executive decision support, AI-enabled CI
Prior: Novartis, Glenmark, Cipla, Syneos Health
Trial assessment, landscaping, congress and regulatory intelligence
Prior: Novartis, Roche, Molekule Consulting
Market intelligence, scenarios, brand and launch strategy
Prior: Novartis, Lupin, MSD
CI planning, congress coverage, landscaping, social media intelligence
Prior: Sun Pharma; 8+ years academic research
Regulatory intelligence, CI monitoring, CI landscaping
Prior: Sun Pharma, Ranbaxy
Early-pipeline intelligence, trial assessment, on-site ASCO and ESMO
Career: 7+ years at AdametNext
We work as an extension of your CI and brand teams. Our clients are directors and heads of competitive intelligence, strategic insights and brand at innovative biopharma companies.
Scientific, clinical, regulatory and commercial lenses. 7+ years as an extension of client teams.
Secondary, primary and congress CI combined, so you anticipate moves and avoid blind spots.
Expert judgement with AI workflows: faster, consistent, scalable and cost-efficient.
Our hybrid model puts consultants close to the markets that matter, backed by our delivery centre in Hyderabad.
Toronto
Short Hills, NJ
London
EU4
Dubai
Delhi
Hyderabad (HQ)
Singapore
BrisbaneFreelance consultant network: Canada, France, Germany, Italy, Spain, UAE and Australia.
Who we are, how we work and why biopharma CI leaders trust us, in a little over two minutes.
10+ biopharma clients rely on our pharma-insider team for primary and secondary CI, across therapy areas and indications.
The shared insights were spot-on.
The attention to detail in finding business implications was commendable.
Current and past clients, many with preferred-vendor status. Client names are kept confidential.
Every engagement is measured against how our clients feel walking into the room with leadership.
Anonymized examples of how our CI shaped real portfolio and brand decisions.
The question · What we did · What we found · Decision supported.
The question · What we did · What we found · Decision supported.
The question · What we did · What we found · Decision supported.
Our latest LinkedIn thinking, signature white papers, and the events where we bring the CI community together.
Congress takeaways, market pulses and CI perspectives from our team and ADN Academy. The newest post always leads.
Follow AdametNextOur latest thought leadership lives on LinkedIn. See all posts ↗
Two practical frameworks from our practice, free to download for biopharma professionals.
A five-step model for deciding where CI investment protects the most future value. It combines the BCG growth-share matrix, Porter’s five forces, brand sensitivity and return on protection into one Protection Priority Score, with a case study on US severe asthma biologics.
A practical compliance framework for ethical competitive intelligence in pharma, covering secondary research, KOL engagement, conference coverage and vendor due diligence across the US, EU and UK.
From Asia’s largest life sciences convention to the leading US CI gathering, our team is on the ground every year. Come and meet us.
Book a meeting at an event →Asia’s largest life sciences & health-tech convention · Hyderabad
We exhibit at BioAsia every year. It happens in Hyderabad, India’s pharma GCC capital and home to our delivery centre. Visit our stand to see our AI-led CI platforms and meet the team.
Connect. Exchange. Elevate.
A practitioner-led community and one-day conference for people building pharma and biopharma capability in India. It brings together GCC leaders and professionals from analytics, R&D, medical, regulatory and technology through keynotes, panels, roundtables and case studies. It’s built for exchange, not a sales showcase. AdametNext is proud to be the Title Sponsor.
Conference & Exhibition · New Jersey
The leading US gathering for pharma competitive intelligence professionals. Visit our booth to see our AI platforms in action and talk through your 2028 CI plan.
New Jersey, USA · We exhibited
“A few themes stand out when you look specifically at what pharma company speakers are discussing at Pharma CI USA 2026.”
235 attendees from 80+ pharma companies came together in Hyderabad for the first edition, convened by AdametNext.
We were at the 23rd edition, themed “TechBio Unleashed: AI, Automation & the Biology Revolution”, alongside 4,000+ delegates.
CI frameworks, congress takeaways, events and team news, in your feed every week.
Frameworks, congress takeaways and practical CI guidance. No noise.
Breaking into Pharma Competitive Intelligence
Understand global pharma, think strategically and build a future-ready career in competitive intelligence.
Available now in paperback and hardcover on Amazon and Writer’s Pocket. Kindle, Flipkart and Google Books coming soon.
What if you could understand the pharmaceutical industry the way decision-makers inside it do?
When I began my career, I knew pharmacy. I understood medicines, formulations, and markets. But I quickly realised that understanding pharma academically and understanding how the global pharmaceutical industry actually works are two very different things.
I had to learn how companies think about competition, clinical development, market access, strategy, pipelines, launches, and long-term business decisions. I also discovered a field that very few students were being introduced to: Pharma Competitive Intelligence.
I wrote Strategic Advantage: Breaking into Pharma Competitive Intelligence to make that journey easier for you.
This is not a book about simply tracking competitors or collecting information.
It is a practical guide to understanding how the global pharmaceutical industry works, how competitive signals shape business decisions, and how you can build the skills required to think more strategically.
Most importantly, this book is designed to help you see pharma differently.
From how the industry really works to building the profile that gets you hired, and staying strategically relevant as your career grows.
“Finally, a book that demystifies Competitive Intelligence and shows how to build a career with purpose and impact. A must-read for aspiring CI professionals.”
In A Conversation on Real Growth, Virendra shares three powerful lessons on entrepreneurship, leadership and success, drawn from his journey from client-side CI to founding AdametNext.
Watch on YouTubeA competitive intelligence professional with 16+ years in the pharmaceutical industry. He has built and led CI functions, partnered with global stakeholders and driven strategic decisions across therapies, in a client-side career spanning Bayer, GSK and Novartis, before founding AdametNext in 2019.
Passionate about developing talent, Virendra now helps aspiring CI professionals build meaningful careers and create real impact.
Order your copy, or contact us about bulk orders for universities, colleges and teams.
Bulk and institutional orders →Work on the questions that shape global biopharma portfolios, alongside former brand and CI leaders, with AI tools that let you focus on insight.
At ADN, analysts don’t just compile information. They learn to read signals the way a brand team would and to defend an implication in front of senior stakeholders.
Work directly with CI and brand teams at top-20 pharma and US biotechs.
Build expertise across oncology, immunology, respiratory, neurology, rare disease and vaccines.
Use our proprietary platforms and AlphaSense, Citeline, Cortellis and IQVIA every day.
Cover major congresses such as ASCO and ESMO, on site and virtually.
Structured mentoring, therapy-area ownership and client-facing responsibility at every stage.
Our internship programme is how we build the next generation of AdametNext analysts. Interns work on live CI for global biopharma clients, guided by former brand and CI leaders. Eligible, high-performing interns are offered full-time roles based on the impact they create during their internship.
Email your CV, institution and the therapy areas that interest you to career@adametnext.com.
Join a client team on real CI deliverables: landscapes, monitoring, congress coverage.
Learn from mentors, own your work and show how you think. Impact is what we assess.
Eligible, high-performing interns are offered full-time roles as analysts.
We are always keen to meet experienced CI, insights and therapy-area specialists, as well as onshore freelance consultants in the US, UK and EU4.
Share your CV, therapy-area experience and the kind of role you are looking for. We will reach out when there is a fit.
A close-knit team of 35+ specialists who learn together, challenge each other and celebrate the work.
Strategic thinkers who ask better questions and uncover what others miss.
Partners who collaborate, challenge assumptions and guide with integrity.
We strongly believe in a culture where work and life are both celebrated. The atmosphere at AdametNext is energetic and vibrant, because great intelligence comes from people who enjoy what they do and who they do it with.
Browse our albums, from festival celebrations to our famous offsites.
Festivals, offsites, wins and everyday moments. Our Instagram is where the AdametNext culture comes alive.
One asset. One therapy area. One strategic question. Tell us what you are facing and we will reply within one business day.
51 JFK Parkway, Short Hills, NJ 07078
Hyderabad, Telangana 500032
The week the industry sets out its guidance, pipeline priorities and deal agenda for the year.
Four days, hundreds of presentations and a steady stream of BD&L news make it easy to miss the signals that matter to your portfolio. We will track them for you, at no cost and with no commitment.
Source-backed and tailored to the competitors and therapy areas you name. Delivered by our CI analysts with ConferaIQ, our AI-enabled conference intelligence platform.
Reply with your priority competitors or therapy areas, and we would welcome a brief 20-minute call before the conference.
Ananya Mehra, Assistant Client Management | AdametNext · Ananya.Mehra01@adametnext.com
Let’s explore it together in a 20-minute introductory conversation.
Book a conversation →Internships are our pathway into AdametNext. Send your CV and the therapy areas that interest you.
Apply for an internship →Careers emailcareer@adametnext.com